March 2, 2020 / 7:10 AM / a month ago

BRIEF-DiaSorin Signs Exclusive License Deal With TTP For Molecular Diagnostic Technology

March 2 (Reuters) - DiaSorin SpA:

* SIGNS EXCLUSIVE LICENSE AGREEMENT WITH TTP FOR DEVELOPMENT OF MOLECULAR POINT-OF-CARE SOLUTION Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below